Table 1 Baseline patient-specific and procedural characteristics of the entire cohort
|  | Entire cohort (n = 335) |
|---|---|
Patient-specific parameters | |
 Age (years) | 62 ± 10 |
 Gender (male/female) | 290 (87%)/ 45 (13%) |
 Alcohol abuse | 117 (35%) |
 Smoking | 170 (51%) |
 Neoadjuvant RCT | 262 (78%) |
 ASA 1/ 2/ 3/ 4 (n) | 10 (3%)/183 (55%)/137 (41%)/5 (2%) |
 BMI (kg/m2) | 24 (5) |
 UICC I/ II | 251 (75%) |
 UICC III/ IV | 84 (25%) |
Procedural parameters | |
 Surgery-related | |
  Surgical approach | |
   Transhiatal | 26 (8%) |
   Thoracoabdominal | 309 (92%) |
  Reconstruction | |
   Gastric tube | 321 (96%) |
   Colon interposition | 14 (4%) |
   Duration of surgery (hours) | 7.0 (2.2) |
   Blood loss (ml) | 700 (600) |
 Anesthesia-related | |
 Average Norepinephrine (μg/kg/min) | 0.03 (0.07) |
 Crystalloids (ml) | 5500 (3000) |
 FFP (ml) | 136 ± 760 |
 PRBC (ml) | 426 ± 1188 |
 Colloids (ml) | 1000 (500) |
 TEA | 286 (85%) |
 TIVA/Gas | 94 (28%) / 240 (72%) |
 Isoflurane | 188 (56%) |
 Desflurane | 50 (15%) |
 Sevoflurane | 2 (0.6%) |
 Hospital stay (days) | 22 (19) |
 ICU stay (days) | 8 (7) |
 30-days-mortality overall | 17 (5%) |
 90-days-mortality overall | 37 (11%) |
 Pneumonia | 114 (34%) |
 Pleural effusion | 104 (31%) |
 New postoperative thoracic drainage | 51 (15%) |
 Chylothorax | 23 (7%) |
 Pleural empyema | 18 (5%) |
 Re-intubation | 66 (20%) |
 Tracheostomy | 39 (12%) |
 Re-intubation followed by tracheostomy | 37 (11%) |
 PPCs | 175 (52%) |
 90-days-mortality with PPCs | 26 (8%) |